社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
KenT
IP属地：未知
+关注
帖子 · 26
帖子 · 26
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
KenT
KenT
·
2021-10-25
D
非常抱歉，此主贴已删除
看
2,962
回复
1
点赞
3
编组 21备份 2
分享
举报
KenT
KenT
·
2021-10-21
D
非常抱歉，此主贴已删除
看
1,910
回复
评论
点赞
3
编组 21备份 2
分享
举报
KenT
KenT
·
2021-10-19
D
Why Johnson & Johnson Will Be a Bigger Winner With Boosters Than Pfizer and Moderna<blockquote>为什么强生公司将成为比辉瑞和Moderna更大的助推器赢家</blockquote>
It's looking like COVID-19 boosters will go three-for-three in winning authorizations. An advisory c
Why Johnson & Johnson Will Be a Bigger Winner With Boosters Than Pfizer and Moderna<blockquote>为什么强生公司将成为比辉瑞和Moderna更大的助推器赢家</blockquote>
看
2,996
回复
1
点赞
7
编组 21备份 2
分享
举报
KenT
KenT
·
2021-10-11
D
Apple stock rose more than 1% in morning trading<blockquote>苹果股价早盘上涨逾1%</blockquote>
Apple stock rose more than 1% in morning trading.Apple appealed the Epic Games ruling and asked to p
Apple stock rose more than 1% in morning trading<blockquote>苹果股价早盘上涨逾1%</blockquote>
看
1,693
回复
评论
点赞
6
编组 21备份 2
分享
举报
KenT
KenT
·
2021-10-06
D
非常抱歉，此主贴已删除
看
2,049
回复
1
点赞
8
编组 21备份 2
分享
举报
KenT
KenT
·
2021-10-01
D
Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>默克公司推出前景光明的口服新冠药物，股市将于10月初反弹</blockquote>
WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward re
Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>默克公司推出前景光明的口服新冠药物，股市将于10月初反弹</blockquote>
看
1,701
回复
评论
点赞
10
编组 21备份 2
分享
举报
KenT
KenT
·
2021-09-29
D
Greenidge Generation stock poped 33% in morning trading<blockquote>Greenidge Generation股价早盘上涨33%</blockquote>
Greenidge Generation stock poped 33% in morning trading. While not an original meme stock, Greenrid
Greenidge Generation stock poped 33% in morning trading<blockquote>Greenidge Generation股价早盘上涨33%</blockquote>
看
1,806
回复
3
点赞
7
编组 21备份 2
分享
举报
KenT
KenT
·
2021-09-28
D
非常抱歉，此主贴已删除
看
2,138
回复
1
点赞
4
编组 21备份 2
分享
举报
KenT
KenT
·
2021-09-27
D
Debt ceiling debates in Congress, consumer confidence: What to know this week<blockquote>国会债务上限辩论、消费者信心：本周需要了解什么</blockquote>
Investors this week are set to closely monitor developments in Washington, D.C., as lawmakers race t
Debt ceiling debates in Congress, consumer confidence: What to know this week<blockquote>国会债务上限辩论、消费者信心：本周需要了解什么</blockquote>
看
1,917
回复
评论
点赞
5
编组 21备份 2
分享
举报
KenT
KenT
·
2021-09-21
D
非常抱歉，此主贴已删除
看
1,685
回复
评论
点赞
4
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3580341419226466","uuid":"3580341419226466","gmtCreate":1617248609406,"gmtModify":1617248609406,"name":"KenT","pinyin":"kent","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":2,"tweetSize":26,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.10.24","exceedPercentage":"60.46%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.01.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":856063759,"gmtCreate":1635130672038,"gmtModify":1635130672194,"author":{"id":"3580341419226466","authorId":"3580341419226466","name":"KenT","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580341419226466","idStr":"3580341419226466"},"themes":[],"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/856063759","repostId":"1129647710","repostType":4,"isVote":1,"tweetType":1,"viewCount":2962,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":853587412,"gmtCreate":1634824666484,"gmtModify":1634825716984,"author":{"id":"3580341419226466","authorId":"3580341419226466","name":"KenT","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580341419226466","idStr":"3580341419226466"},"themes":[],"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/853587412","repostId":"1143424467","repostType":4,"isVote":1,"tweetType":1,"viewCount":1910,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":859026670,"gmtCreate":1634641857853,"gmtModify":1634641898279,"author":{"id":"3580341419226466","authorId":"3580341419226466","name":"KenT","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580341419226466","idStr":"3580341419226466"},"themes":[],"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/859026670","repostId":"1110674401","repostType":4,"repost":{"id":"1110674401","kind":"news","pubTimestamp":1634641816,"share":"https://www.laohu8.com/m/news/1110674401?lang=zh_CN&edition=full","pubTime":"2021-10-19 19:10","market":"us","language":"en","title":"Why Johnson & Johnson Will Be a Bigger Winner With Boosters Than Pfizer and Moderna<blockquote>为什么强生公司将成为比辉瑞和Moderna更大的助推器赢家</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1110674401","media":"Motley Fool","summary":"It's looking like COVID-19 boosters will go three-for-three in winning authorizations.\nAn advisory c","content":"<p>It's looking like COVID-19 boosters will go three-for-three in winning authorizations.</p><p><blockquote>看起来新冠肺炎的支持者将以三比三赢得授权。</blockquote></p><p> An advisory committee to the U.S. Food and Drug Administration (FDA) voted unanimously last week in support of boosters for <b>Moderna</b>'s(NASDAQ:MRNA) COVID-19 vaccine and for <b>Johnson & Johnson</b>'s(NYSE:JNJ)vaccine. The FDA has already granted Emergency Use Authorization (EUA) to boosters for the COVID-19 vaccine marketed by <b>Pfizer</b>(NYSE:PFE) and its partner <b>BioNTech</b>(NASDAQ:BNTX).</p><p><blockquote>美国的一个咨询委员会。美国食品和药物管理局(FDA)上周一致投票支持加强剂<b>现代</b>的（纳斯达克：MRNA）COVID-19疫苗和用于<b>强生公司</b>（纽约证券交易所股票代码：JNJ）疫苗。FDA已向以下公司销售的COVID-19疫苗加强剂授予紧急使用授权(EUA)<b>辉瑞</b>（纽约证券交易所代码：PFE）及其合作伙伴<b>BioNTech</b>（纳斯达克：BNTX）。</blockquote></p><p> Granted, the FDA doesn't have to go along with the recommendations from the advisory committee. It seems likely, though, that the agency will do so.</p><p><blockquote>诚然，FDA不必同意咨询委员会的建议。不过，该机构似乎很可能会这样做。</blockquote></p><p> Authorizations for boosters is good news for all of these leading COVID-19 vaccine makers. But Johnson & Johnson appears poised to be the bigger winner with boosters than either Moderna or Pfizer.</p><p><blockquote>对所有这些领先的新冠肺炎疫苗制造商来说，加强剂的授权是个好消息。但强生公司似乎有望成为比Moderna或辉瑞更大的赢家。</blockquote></p><p> No restrictions</p><p><blockquote>没有限制</blockquote></p><p> Pfizer's EUA for boosters came with several restrictions. The FDA decided that boosters would be allowed only for individuals ages 65 and older and for individuals ages 18 through 64 who are at high risk for developing severe COVID-19 or who work in environments that could put them at high risk of severe complications from COVID-19.</p><p><blockquote>辉瑞公司的加强剂EUA有几项限制。FDA决定，仅允许65岁及以上的个人以及18至64岁的个人使用加强剂，这些人有患严重新冠肺炎的高风险，或者在可能使他们有患严重新冠肺炎并发症的高风险的环境中工作。</blockquote></p><p> The FDA advisory committee's vote for Moderna boosters mirrored the restrictions for the Pfizer-BioNTech vaccine. Assuming the FDA follows that recommendation, Moderna's market opportunity for booster doses will be just as limited as that of Pfizer and BioNTech.</p><p><blockquote>FDA咨询委员会对Moderna加强剂的投票反映了对辉瑞-BioNTech疫苗的限制。假设FDA遵循这一建议，Moderna的加强剂量市场机会将与辉瑞和BioNTech一样有限。</blockquote></p><p> However, the FDA panel placed no such restrictions on boosters for Johnson & Johnson's COVID-19 vaccine. Again, assuming the FDA goes along with the committee's recommendation, J&J's booster will be available to adults ages 18 and older at least two months after they received the first shot of the J&J vaccine.</p><p><blockquote>然而，FDA小组对强生公司新冠肺炎疫苗的加强剂没有这样的限制。同样，假设FDA同意委员会的建议，强生的加强剂将在18岁及以上的成年人接种第一针强生疫苗后至少两个月提供给他们。</blockquote></p><p> The Moderna and Pfizer-BioNTech vaccines require two initial doses whereas Johnson & Johnson's vaccine initially requires only a single dose. J&J's vaccine also provided lower efficacy than its rival messenger RNA (mRNA) vaccines. These factors heavily influenced the FDA advisory committee's decision to recommend broader use of boosters with the J&J vaccine.</p><p><blockquote>Moderna和辉瑞-BioNTech疫苗需要两剂初始剂量，而强生公司的疫苗最初只需要一剂。强生公司的疫苗效力也低于其竞争对手的信使RNA(mRNA)疫苗。这些因素严重影响了FDA咨询委员会建议更广泛使用强生疫苗加强剂的决定。</blockquote></p><p> Winning is relative</p><p><blockquote>胜利是相对的</blockquote></p><p> The demand for Johnson & Johnson boosters should be much greater as a percentage of initial vaccinations than it will be for Moderna and Pfizer-BioNTech boosters. From that standpoint, J&J will almost certainly be a bigger winner with booster shots than its rivals.</p><p><blockquote>对强生加强剂的需求占初始疫苗接种的百分比应该比对Moderna和辉瑞-BioNTech加强剂的需求大得多。从这个角度来看，强生几乎肯定会成为比竞争对手更大的赢家。</blockquote></p><p> However, the term \"winning\" is relative in this case. Johnson & Johnson has committed to selling its COVID-19 vaccine at cost during the pandemic. Boosters won't add a dime to the healthcare giant's profits over the near term.</p><p><blockquote>然而，在这种情况下，术语“获胜”是相对的。强生公司承诺在疫情期间以成本价销售其COVID-19疫苗。短期内，助推器不会为这家医疗保健巨头的利润增加一分钱。</blockquote></p><p> Also, only around 23.7 million doses of Johnson & Johnson's single-shot vaccine have been given in the U.S., according to the Centers for Disease Control & Prevention (CDC). By comparison, the total doses administered stands at 192.8 million for Moderna's vaccine and 278.1 million doses for the Pfizer-BioNTech vaccine. Even without the restrictions imposed on boosters for rival mRNA vaccines, the pool for J&J boosters is much smaller.</p><p><blockquote>此外，根据疾病控制与预防中心（CDC）的数据，美国仅注射了约2370万剂强生公司的单针疫苗。相比之下，Moderna疫苗的总剂量为1.928亿剂，辉瑞-BioNTech疫苗的总剂量为2.781亿剂。即使没有对竞争对手mRNA疫苗加强剂的限制，强生加强剂的数量也要小得多。</blockquote></p><p> Perhaps the most important thing to understand is that EUAs for boosters isn't likely to lead to higher sales for any of these vaccine makers over the short term. The U.S. government has already ordered more than enough doses of all three vaccines to provide boosters to everyone who has already been fully vaccinated plus meet the needs for the remaining Americans who haven't been vaccinated.</p><p><blockquote>也许需要理解的最重要的事情是，加强剂的EUA不太可能在短期内为这些疫苗制造商带来更高的销售额。美国政府已经订购了足够剂量的所有三种疫苗，为所有已经完全接种疫苗的人提供加强剂，并满足其余未接种疫苗的美国人的需求。</blockquote></p><p> A different long-term picture</p><p><blockquote>不同的长期图景</blockquote></p><p> There could be a much different picture over the long term. Europe has already recommended boosters for the Pfizer-BioNTech vaccine without the restrictions adopted in the U.S. It's possible that the U.S. could follow in Europe's footsteps in the not-too-distant future with the Pfizer and Moderna vaccines.</p><p><blockquote>从长远来看，情况可能会大不相同。欧洲已经推荐了辉瑞-BioNTech疫苗的加强剂，而没有美国采取的限制。在不久的将来，美国可能会追随欧洲的脚步，使用辉瑞和Moderna疫苗。</blockquote></p><p> As a result, boosters could eventually provide solid catalysts for mRNA vaccine stocks. There is some uncertainty about recurring revenue from COVID-19 vaccines after the pandemic is over. If there is a clear need for boosters at least on an annual basis, the leading vaccine makers should be able to count on strong sales continuing for years.</p><p><blockquote>因此，加强剂最终可以为mRNA疫苗库存提供固体催化剂。大流行结束后，COVID-19疫苗的经常性收入存在一些不确定性。如果至少每年都有对加强剂的明确需求，领先的疫苗制造商应该能够指望持续多年的强劲销售。</blockquote></p><p> However, the long-term dynamics could make it less likely that Johnson & Johnson keeps up its winning ways. Moderna and the Pfizer-BioNTech team appear to be ahead of J&J in developing new vaccine versions that target emerging coronavirus variants. The flexibility of these companies' mRNA technology could provide significant advantages in responding rapidly to new viral threats.</p><p><blockquote>然而，长期动态可能会降低强生公司继续获胜的可能性。Moderna和辉瑞-BioNTech团队在开发针对新出现的冠状病毒变种的新疫苗版本方面似乎领先于强生。这些公司的mRNA技术的灵活性可以在快速应对新的病毒威胁方面提供显著优势。</blockquote></p><p> Johnson & Johnson undoubtedly wants to be a major player in the COVID-19 vaccine market for years to come. And perhaps it will. The good news for the company and its shareholders is that it doesn't have to win in COVID-19 to still be successful overall.</p><p><blockquote>强生公司无疑希望在未来几年成为新冠肺炎疫苗市场的主要参与者。也许它会。对于该公司及其股东来说，好消息是，它不一定要在COVID-19中获胜才能保持整体成功。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Johnson & Johnson Will Be a Bigger Winner With Boosters Than Pfizer and Moderna<blockquote>为什么强生公司将成为比辉瑞和Moderna更大的助推器赢家</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Johnson & Johnson Will Be a Bigger Winner With Boosters Than Pfizer and Moderna<blockquote>为什么强生公司将成为比辉瑞和Moderna更大的助推器赢家</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-10-19 19:10</span>\n</p>\n</h4>\n</header>\n<article>\n<p>It's looking like COVID-19 boosters will go three-for-three in winning authorizations.</p><p><blockquote>看起来新冠肺炎的支持者将以三比三赢得授权。</blockquote></p><p> An advisory committee to the U.S. Food and Drug Administration (FDA) voted unanimously last week in support of boosters for <b>Moderna</b>'s(NASDAQ:MRNA) COVID-19 vaccine and for <b>Johnson & Johnson</b>'s(NYSE:JNJ)vaccine. The FDA has already granted Emergency Use Authorization (EUA) to boosters for the COVID-19 vaccine marketed by <b>Pfizer</b>(NYSE:PFE) and its partner <b>BioNTech</b>(NASDAQ:BNTX).</p><p><blockquote>美国的一个咨询委员会。美国食品和药物管理局(FDA)上周一致投票支持加强剂<b>现代</b>的（纳斯达克：MRNA）COVID-19疫苗和用于<b>强生公司</b>（纽约证券交易所股票代码：JNJ）疫苗。FDA已向以下公司销售的COVID-19疫苗加强剂授予紧急使用授权(EUA)<b>辉瑞</b>（纽约证券交易所代码：PFE）及其合作伙伴<b>BioNTech</b>（纳斯达克：BNTX）。</blockquote></p><p> Granted, the FDA doesn't have to go along with the recommendations from the advisory committee. It seems likely, though, that the agency will do so.</p><p><blockquote>诚然，FDA不必同意咨询委员会的建议。不过，该机构似乎很可能会这样做。</blockquote></p><p> Authorizations for boosters is good news for all of these leading COVID-19 vaccine makers. But Johnson & Johnson appears poised to be the bigger winner with boosters than either Moderna or Pfizer.</p><p><blockquote>对所有这些领先的新冠肺炎疫苗制造商来说，加强剂的授权是个好消息。但强生公司似乎有望成为比Moderna或辉瑞更大的赢家。</blockquote></p><p> No restrictions</p><p><blockquote>没有限制</blockquote></p><p> Pfizer's EUA for boosters came with several restrictions. The FDA decided that boosters would be allowed only for individuals ages 65 and older and for individuals ages 18 through 64 who are at high risk for developing severe COVID-19 or who work in environments that could put them at high risk of severe complications from COVID-19.</p><p><blockquote>辉瑞公司的加强剂EUA有几项限制。FDA决定，仅允许65岁及以上的个人以及18至64岁的个人使用加强剂，这些人有患严重新冠肺炎的高风险，或者在可能使他们有患严重新冠肺炎并发症的高风险的环境中工作。</blockquote></p><p> The FDA advisory committee's vote for Moderna boosters mirrored the restrictions for the Pfizer-BioNTech vaccine. Assuming the FDA follows that recommendation, Moderna's market opportunity for booster doses will be just as limited as that of Pfizer and BioNTech.</p><p><blockquote>FDA咨询委员会对Moderna加强剂的投票反映了对辉瑞-BioNTech疫苗的限制。假设FDA遵循这一建议，Moderna的加强剂量市场机会将与辉瑞和BioNTech一样有限。</blockquote></p><p> However, the FDA panel placed no such restrictions on boosters for Johnson & Johnson's COVID-19 vaccine. Again, assuming the FDA goes along with the committee's recommendation, J&J's booster will be available to adults ages 18 and older at least two months after they received the first shot of the J&J vaccine.</p><p><blockquote>然而，FDA小组对强生公司新冠肺炎疫苗的加强剂没有这样的限制。同样，假设FDA同意委员会的建议，强生的加强剂将在18岁及以上的成年人接种第一针强生疫苗后至少两个月提供给他们。</blockquote></p><p> The Moderna and Pfizer-BioNTech vaccines require two initial doses whereas Johnson & Johnson's vaccine initially requires only a single dose. J&J's vaccine also provided lower efficacy than its rival messenger RNA (mRNA) vaccines. These factors heavily influenced the FDA advisory committee's decision to recommend broader use of boosters with the J&J vaccine.</p><p><blockquote>Moderna和辉瑞-BioNTech疫苗需要两剂初始剂量，而强生公司的疫苗最初只需要一剂。强生公司的疫苗效力也低于其竞争对手的信使RNA(mRNA)疫苗。这些因素严重影响了FDA咨询委员会建议更广泛使用强生疫苗加强剂的决定。</blockquote></p><p> Winning is relative</p><p><blockquote>胜利是相对的</blockquote></p><p> The demand for Johnson & Johnson boosters should be much greater as a percentage of initial vaccinations than it will be for Moderna and Pfizer-BioNTech boosters. From that standpoint, J&J will almost certainly be a bigger winner with booster shots than its rivals.</p><p><blockquote>对强生加强剂的需求占初始疫苗接种的百分比应该比对Moderna和辉瑞-BioNTech加强剂的需求大得多。从这个角度来看，强生几乎肯定会成为比竞争对手更大的赢家。</blockquote></p><p> However, the term \"winning\" is relative in this case. Johnson & Johnson has committed to selling its COVID-19 vaccine at cost during the pandemic. Boosters won't add a dime to the healthcare giant's profits over the near term.</p><p><blockquote>然而，在这种情况下，术语“获胜”是相对的。强生公司承诺在疫情期间以成本价销售其COVID-19疫苗。短期内，助推器不会为这家医疗保健巨头的利润增加一分钱。</blockquote></p><p> Also, only around 23.7 million doses of Johnson & Johnson's single-shot vaccine have been given in the U.S., according to the Centers for Disease Control & Prevention (CDC). By comparison, the total doses administered stands at 192.8 million for Moderna's vaccine and 278.1 million doses for the Pfizer-BioNTech vaccine. Even without the restrictions imposed on boosters for rival mRNA vaccines, the pool for J&J boosters is much smaller.</p><p><blockquote>此外，根据疾病控制与预防中心（CDC）的数据，美国仅注射了约2370万剂强生公司的单针疫苗。相比之下，Moderna疫苗的总剂量为1.928亿剂，辉瑞-BioNTech疫苗的总剂量为2.781亿剂。即使没有对竞争对手mRNA疫苗加强剂的限制，强生加强剂的数量也要小得多。</blockquote></p><p> Perhaps the most important thing to understand is that EUAs for boosters isn't likely to lead to higher sales for any of these vaccine makers over the short term. The U.S. government has already ordered more than enough doses of all three vaccines to provide boosters to everyone who has already been fully vaccinated plus meet the needs for the remaining Americans who haven't been vaccinated.</p><p><blockquote>也许需要理解的最重要的事情是，加强剂的EUA不太可能在短期内为这些疫苗制造商带来更高的销售额。美国政府已经订购了足够剂量的所有三种疫苗，为所有已经完全接种疫苗的人提供加强剂，并满足其余未接种疫苗的美国人的需求。</blockquote></p><p> A different long-term picture</p><p><blockquote>不同的长期图景</blockquote></p><p> There could be a much different picture over the long term. Europe has already recommended boosters for the Pfizer-BioNTech vaccine without the restrictions adopted in the U.S. It's possible that the U.S. could follow in Europe's footsteps in the not-too-distant future with the Pfizer and Moderna vaccines.</p><p><blockquote>从长远来看，情况可能会大不相同。欧洲已经推荐了辉瑞-BioNTech疫苗的加强剂，而没有美国采取的限制。在不久的将来，美国可能会追随欧洲的脚步，使用辉瑞和Moderna疫苗。</blockquote></p><p> As a result, boosters could eventually provide solid catalysts for mRNA vaccine stocks. There is some uncertainty about recurring revenue from COVID-19 vaccines after the pandemic is over. If there is a clear need for boosters at least on an annual basis, the leading vaccine makers should be able to count on strong sales continuing for years.</p><p><blockquote>因此，加强剂最终可以为mRNA疫苗库存提供固体催化剂。大流行结束后，COVID-19疫苗的经常性收入存在一些不确定性。如果至少每年都有对加强剂的明确需求，领先的疫苗制造商应该能够指望持续多年的强劲销售。</blockquote></p><p> However, the long-term dynamics could make it less likely that Johnson & Johnson keeps up its winning ways. Moderna and the Pfizer-BioNTech team appear to be ahead of J&J in developing new vaccine versions that target emerging coronavirus variants. The flexibility of these companies' mRNA technology could provide significant advantages in responding rapidly to new viral threats.</p><p><blockquote>然而，长期动态可能会降低强生公司继续获胜的可能性。Moderna和辉瑞-BioNTech团队在开发针对新出现的冠状病毒变种的新疫苗版本方面似乎领先于强生。这些公司的mRNA技术的灵活性可以在快速应对新的病毒威胁方面提供显著优势。</blockquote></p><p> Johnson & Johnson undoubtedly wants to be a major player in the COVID-19 vaccine market for years to come. And perhaps it will. The good news for the company and its shareholders is that it doesn't have to win in COVID-19 to still be successful overall.</p><p><blockquote>强生公司无疑希望在未来几年成为新冠肺炎疫苗市场的主要参与者。也许它会。对于该公司及其股东来说，好消息是，它不一定要在COVID-19中获胜才能保持整体成功。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/10/19/why-johnson-johnson-winner-boosters-pfizer-moderna/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.fool.com/investing/2021/10/19/why-johnson-johnson-winner-boosters-pfizer-moderna/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110674401","content_text":"It's looking like COVID-19 boosters will go three-for-three in winning authorizations.\nAn advisory committee to the U.S. Food and Drug Administration (FDA) voted unanimously last week in support of boosters for Moderna's(NASDAQ:MRNA) COVID-19 vaccine and for Johnson & Johnson's(NYSE:JNJ)vaccine. The FDA has already granted Emergency Use Authorization (EUA) to boosters for the COVID-19 vaccine marketed by Pfizer(NYSE:PFE) and its partner BioNTech(NASDAQ:BNTX).\nGranted, the FDA doesn't have to go along with the recommendations from the advisory committee. It seems likely, though, that the agency will do so.\nAuthorizations for boosters is good news for all of these leading COVID-19 vaccine makers. But Johnson & Johnson appears poised to be the bigger winner with boosters than either Moderna or Pfizer.\nNo restrictions\nPfizer's EUA for boosters came with several restrictions. The FDA decided that boosters would be allowed only for individuals ages 65 and older and for individuals ages 18 through 64 who are at high risk for developing severe COVID-19 or who work in environments that could put them at high risk of severe complications from COVID-19.\nThe FDA advisory committee's vote for Moderna boosters mirrored the restrictions for the Pfizer-BioNTech vaccine. Assuming the FDA follows that recommendation, Moderna's market opportunity for booster doses will be just as limited as that of Pfizer and BioNTech.\nHowever, the FDA panel placed no such restrictions on boosters for Johnson & Johnson's COVID-19 vaccine. Again, assuming the FDA goes along with the committee's recommendation, J&J's booster will be available to adults ages 18 and older at least two months after they received the first shot of the J&J vaccine.\nThe Moderna and Pfizer-BioNTech vaccines require two initial doses whereas Johnson & Johnson's vaccine initially requires only a single dose. J&J's vaccine also provided lower efficacy than its rival messenger RNA (mRNA) vaccines. These factors heavily influenced the FDA advisory committee's decision to recommend broader use of boosters with the J&J vaccine.\nWinning is relative\nThe demand for Johnson & Johnson boosters should be much greater as a percentage of initial vaccinations than it will be for Moderna and Pfizer-BioNTech boosters. From that standpoint, J&J will almost certainly be a bigger winner with booster shots than its rivals.\nHowever, the term \"winning\" is relative in this case. Johnson & Johnson has committed to selling its COVID-19 vaccine at cost during the pandemic. Boosters won't add a dime to the healthcare giant's profits over the near term.\nAlso, only around 23.7 million doses of Johnson & Johnson's single-shot vaccine have been given in the U.S., according to the Centers for Disease Control & Prevention (CDC). By comparison, the total doses administered stands at 192.8 million for Moderna's vaccine and 278.1 million doses for the Pfizer-BioNTech vaccine. Even without the restrictions imposed on boosters for rival mRNA vaccines, the pool for J&J boosters is much smaller.\nPerhaps the most important thing to understand is that EUAs for boosters isn't likely to lead to higher sales for any of these vaccine makers over the short term. The U.S. government has already ordered more than enough doses of all three vaccines to provide boosters to everyone who has already been fully vaccinated plus meet the needs for the remaining Americans who haven't been vaccinated.\nA different long-term picture\nThere could be a much different picture over the long term. Europe has already recommended boosters for the Pfizer-BioNTech vaccine without the restrictions adopted in the U.S. It's possible that the U.S. could follow in Europe's footsteps in the not-too-distant future with the Pfizer and Moderna vaccines.\nAs a result, boosters could eventually provide solid catalysts for mRNA vaccine stocks. There is some uncertainty about recurring revenue from COVID-19 vaccines after the pandemic is over. If there is a clear need for boosters at least on an annual basis, the leading vaccine makers should be able to count on strong sales continuing for years.\nHowever, the long-term dynamics could make it less likely that Johnson & Johnson keeps up its winning ways. Moderna and the Pfizer-BioNTech team appear to be ahead of J&J in developing new vaccine versions that target emerging coronavirus variants. The flexibility of these companies' mRNA technology could provide significant advantages in responding rapidly to new viral threats.\nJohnson & Johnson undoubtedly wants to be a major player in the COVID-19 vaccine market for years to come. And perhaps it will. The good news for the company and its shareholders is that it doesn't have to win in COVID-19 to still be successful overall.","news_type":1,"symbols_score_info":{"JNJ":0.9}},"isVote":1,"tweetType":1,"viewCount":2996,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":826990852,"gmtCreate":1633962403581,"gmtModify":1633962403581,"author":{"id":"3580341419226466","authorId":"3580341419226466","name":"KenT","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580341419226466","idStr":"3580341419226466"},"themes":[],"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/826990852","repostId":"1104700424","repostType":4,"repost":{"id":"1104700424","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633962193,"share":"https://www.laohu8.com/m/news/1104700424?lang=zh_CN&edition=full","pubTime":"2021-10-11 22:23","market":"us","language":"en","title":"Apple stock rose more than 1% in morning trading<blockquote>苹果股价早盘上涨逾1%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1104700424","media":"Tiger Newspress","summary":"Apple stock rose more than 1% in morning trading.Apple appealed the Epic Games ruling and asked to p","content":"<p>Apple stock rose more than 1% in morning trading.Apple appealed the Epic Games ruling and asked to put ordered App Store changes on hold.</p><p><blockquote>苹果股价早盘上涨逾1%。苹果对Epic Games的裁决提出上诉，并要求暂停订购的App Store变更。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2d8c8a6a273d3ea37161e8b6b988da92\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The iPhone maker gave notice last Friday (Oct 8) that it will appeal a judge's ruling in its fight with Epic Games ordering the California-based company to stop blocking developers from letting users complete in-app purchases on the Web.</p><p><blockquote>这家iPhone制造商上周五（10月8日）发出通知，将对法官在与Epic Games的斗争中的裁决提出上诉，该裁决命令这家总部位于加州的公司停止阻止开发者让用户在网络上完成应用内购买。</blockquote></p><p> It also asked the judge to put the Dec 9 deadline for App Store rule changes on hold during the appeal, which, if allowed, could keep business as usual for Apple for at least a year.</p><p><blockquote>它还要求法官在上诉期间暂停12月9日App Store规则变更的最后期限，如果允许，苹果的业务可以照常运行至少一年。</blockquote></p><p> The Sept 10 ruling largely vindicated Apple's business model, which charges commissions on developers for App Store transactions, but the judge said Apple must allow direct communication between users and app makers and permit links to the Web to complete transactions.</p><p><blockquote>9月10日的裁决在很大程度上证明了苹果的商业模式是正确的，该模式向开发者收取应用商店交易佣金，但法官表示，苹果必须允许用户和应用程序制造商之间的直接沟通，并允许链接到网络来完成交易。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple stock rose more than 1% in morning trading<blockquote>苹果股价早盘上涨逾1%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple stock rose more than 1% in morning trading<blockquote>苹果股价早盘上涨逾1%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-11 22:23</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Apple stock rose more than 1% in morning trading.Apple appealed the Epic Games ruling and asked to put ordered App Store changes on hold.</p><p><blockquote>苹果股价早盘上涨逾1%。苹果对Epic Games的裁决提出上诉，并要求暂停订购的App Store变更。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/2d8c8a6a273d3ea37161e8b6b988da92\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> The iPhone maker gave notice last Friday (Oct 8) that it will appeal a judge's ruling in its fight with Epic Games ordering the California-based company to stop blocking developers from letting users complete in-app purchases on the Web.</p><p><blockquote>这家iPhone制造商上周五（10月8日）发出通知，将对法官在与Epic Games的斗争中的裁决提出上诉，该裁决命令这家总部位于加州的公司停止阻止开发者让用户在网络上完成应用内购买。</blockquote></p><p> It also asked the judge to put the Dec 9 deadline for App Store rule changes on hold during the appeal, which, if allowed, could keep business as usual for Apple for at least a year.</p><p><blockquote>它还要求法官在上诉期间暂停12月9日App Store规则变更的最后期限，如果允许，苹果的业务可以照常运行至少一年。</blockquote></p><p> The Sept 10 ruling largely vindicated Apple's business model, which charges commissions on developers for App Store transactions, but the judge said Apple must allow direct communication between users and app makers and permit links to the Web to complete transactions.</p><p><blockquote>9月10日的裁决在很大程度上证明了苹果的商业模式是正确的，该模式向开发者收取应用商店交易佣金，但法官表示，苹果必须允许用户和应用程序制造商之间的直接沟通，并允许链接到网络来完成交易。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104700424","content_text":"Apple stock rose more than 1% in morning trading.Apple appealed the Epic Games ruling and asked to put ordered App Store changes on hold.\n\nThe iPhone maker gave notice last Friday (Oct 8) that it will appeal a judge's ruling in its fight with Epic Games ordering the California-based company to stop blocking developers from letting users complete in-app purchases on the Web.\nIt also asked the judge to put the Dec 9 deadline for App Store rule changes on hold during the appeal, which, if allowed, could keep business as usual for Apple for at least a year.\nThe Sept 10 ruling largely vindicated Apple's business model, which charges commissions on developers for App Store transactions, but the judge said Apple must allow direct communication between users and app makers and permit links to the Web to complete transactions.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":1693,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829190159,"gmtCreate":1633478593311,"gmtModify":1633478593433,"author":{"id":"3580341419226466","authorId":"3580341419226466","name":"KenT","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580341419226466","idStr":"3580341419226466"},"themes":[],"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829190159","repostId":"1101968131","repostType":4,"isVote":1,"tweetType":1,"viewCount":2049,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864693631,"gmtCreate":1633095780105,"gmtModify":1633095816782,"author":{"id":"3580341419226466","authorId":"3580341419226466","name":"KenT","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580341419226466","idStr":"3580341419226466"},"themes":[],"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864693631","repostId":"1145898013","repostType":4,"repost":{"id":"1145898013","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633095114,"share":"https://www.laohu8.com/m/news/1145898013?lang=zh_CN&edition=full","pubTime":"2021-10-01 21:31","market":"us","language":"en","title":"Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>默克公司推出前景光明的口服新冠药物，股市将于10月初反弹</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1145898013","media":"Tiger Newspress","summary":"WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward re","content":"<p>WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.</p><p><blockquote>华盛顿（路透社）-美国。8月份消费者支出增幅超过预期，但对7月份数据的下修保持了对第三季度经济增长放缓的预期不变，因为COVID-19感染的死灰复燃抑制了对服务的需求。</blockquote></p><p> Dow added 260 points, or 0.8%. The S&P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.<img src=\"https://static.tigerbbs.com/0651731f7c9f3c7130af900f3a9a0f3a\" tg-width=\"1352\" tg-height=\"448\" referrerpolicy=\"no-referrer\">Shares of Dow member Merck<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.</p><p><blockquote>道琼斯指数上涨260点，涨幅0.8%。标普500和纳斯达克综合指数分别上涨0.5%和0.2%。道指成员默克公司的股票<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a>该制药商和Ridgeback Biotherapeutics表示，他们针对COVID-19的口服抗病毒治疗将轻度或中度病例患者的住院或死亡风险降低了50%，股价上涨了8%。两家公司计划寻求治疗的紧急授权。美国商务部周五表示，占美国经济活动三分之二以上的消费者支出8月份反弹0.8%，摆脱了全球半导体短缺导致的汽车销量下降的影响，半导体短缺正在削弱汽车产量。</blockquote></p><p> The new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.</p><p><blockquote>默克公司的新药似乎提振了旅游股。皇家加勒比和拉斯维加斯金沙集团的股价在盘前交易中上涨超过1%。摩根大通上调西南航空股票评级并表示该集团大部分股票值得购买后，西南航空领涨航空股。</blockquote></p><p> The 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.</p><p><blockquote>10年期国债收益率早盘回落至1.50%以下。随着收益率下降，以科技股为主的纳斯达克期货上涨。</blockquote></p><p> The market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.</p><p><blockquote>由于通胀担忧、经济增长放缓和利率上升让投资者感到紧张，市场刚刚结束了动荡的九月。标普500本月收盘下跌4.8%，打破了七个月的连涨势头。道琼斯指数和纳斯达克综合指数分别下跌4.3%和5.3%，遭遇今年最糟糕的月份。</blockquote></p><p> “A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.</p><p><blockquote>高盛董事总经理Chris Hussey表示：“随着我们进入秋季和2021年第四季度，经济增长放缓、货币政策宽松程度降低、中国逆风、财政刺激减弱以及供应链瓶颈的困扰，所有这些因素共同打压了投资者的情绪。”在一份说明中说。</blockquote></p><p> Consumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.</p><p><blockquote>第二季度消费者支出以12.0%的年化增长率强劲增长，占经济6.7%增长率的大部分，这使国内生产总值水平高于2019年第四季度的峰值。第三季度的增长率预期低于5.0%。</blockquote></p><p> \"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.</p><p><blockquote>摩根大通基金驻纽约首席全球策略师David Kelly表示：“未来几个月，消费者势头应该会有所改善，推动经济更接近疫情后的全面复苏，并保持通胀高温。”</blockquote></p><p> Inflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.</p><p><blockquote>8月份通胀保持上升趋势。不包括波动较大的食品和能源成分的个人消费支出(PCE)价格指数继7月份上涨相同幅度后上涨0.3%。</blockquote></p><p> In the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.</p><p><blockquote>在截至8月份的12个月中，所谓的核心PCE价格指数上涨了3.6%，与7月份的涨幅相当。</blockquote></p><p> The core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.</p><p><blockquote>核心PCE物价指数是美联储为其灵活的2%目标而首选的通胀指标。美联储上周将今年核心PCE通胀预期从6月份的3.0%上调至3.7%。</blockquote></p><p> The U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.</p><p><blockquote>美联储表示，最早可能在11月开始减少月度债券购买，并暗示加息可能会比预期更快。</blockquote></p><p> Fed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.</p><p><blockquote>美联储主席杰罗姆·鲍威尔周四对立法者表示，他预计未来几个月高通胀将有所缓解。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks rebound to start October on Merck’s promising oral Covid pill<blockquote>默克公司推出前景光明的口服新冠药物，股市将于10月初反弹</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks rebound to start October on Merck’s promising oral Covid pill<blockquote>默克公司推出前景光明的口服新冠药物，股市将于10月初反弹</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-10-01 21:31</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.</p><p><blockquote>华盛顿（路透社）-美国。8月份消费者支出增幅超过预期，但对7月份数据的下修保持了对第三季度经济增长放缓的预期不变，因为COVID-19感染的死灰复燃抑制了对服务的需求。</blockquote></p><p> Dow added 260 points, or 0.8%. The S&P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.<img src=\"https://static.tigerbbs.com/0651731f7c9f3c7130af900f3a9a0f3a\" tg-width=\"1352\" tg-height=\"448\" referrerpolicy=\"no-referrer\">Shares of Dow member Merck<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a> jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.</p><p><blockquote>道琼斯指数上涨260点，涨幅0.8%。标普500和纳斯达克综合指数分别上涨0.5%和0.2%。道指成员默克公司的股票<a href=\"https://laohu8.com/S/MRK\">$(MRK)$</a>该制药商和Ridgeback Biotherapeutics表示，他们针对COVID-19的口服抗病毒治疗将轻度或中度病例患者的住院或死亡风险降低了50%，股价上涨了8%。两家公司计划寻求治疗的紧急授权。美国商务部周五表示，占美国经济活动三分之二以上的消费者支出8月份反弹0.8%，摆脱了全球半导体短缺导致的汽车销量下降的影响，半导体短缺正在削弱汽车产量。</blockquote></p><p> The new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.</p><p><blockquote>默克公司的新药似乎提振了旅游股。皇家加勒比和拉斯维加斯金沙集团的股价在盘前交易中上涨超过1%。摩根大通上调西南航空股票评级并表示该集团大部分股票值得购买后，西南航空领涨航空股。</blockquote></p><p> The 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.</p><p><blockquote>10年期国债收益率早盘回落至1.50%以下。随着收益率下降，以科技股为主的纳斯达克期货上涨。</blockquote></p><p> The market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.</p><p><blockquote>由于通胀担忧、经济增长放缓和利率上升让投资者感到紧张，市场刚刚结束了动荡的九月。标普500本月收盘下跌4.8%，打破了七个月的连涨势头。道琼斯指数和纳斯达克综合指数分别下跌4.3%和5.3%，遭遇今年最糟糕的月份。</blockquote></p><p> “A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.</p><p><blockquote>高盛董事总经理Chris Hussey表示：“随着我们进入秋季和2021年第四季度，经济增长放缓、货币政策宽松程度降低、中国逆风、财政刺激减弱以及供应链瓶颈的困扰，所有这些因素共同打压了投资者的情绪。”在一份说明中说。</blockquote></p><p> Consumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.</p><p><blockquote>第二季度消费者支出以12.0%的年化增长率强劲增长，占经济6.7%增长率的大部分，这使国内生产总值水平高于2019年第四季度的峰值。第三季度的增长率预期低于5.0%。</blockquote></p><p> \"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.</p><p><blockquote>摩根大通基金驻纽约首席全球策略师David Kelly表示：“未来几个月，消费者势头应该会有所改善，推动经济更接近疫情后的全面复苏，并保持通胀高温。”</blockquote></p><p> Inflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.</p><p><blockquote>8月份通胀保持上升趋势。不包括波动较大的食品和能源成分的个人消费支出(PCE)价格指数继7月份上涨相同幅度后上涨0.3%。</blockquote></p><p> In the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.</p><p><blockquote>在截至8月份的12个月中，所谓的核心PCE价格指数上涨了3.6%，与7月份的涨幅相当。</blockquote></p><p> The core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.</p><p><blockquote>核心PCE物价指数是美联储为其灵活的2%目标而首选的通胀指标。美联储上周将今年核心PCE通胀预期从6月份的3.0%上调至3.7%。</blockquote></p><p> The U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.</p><p><blockquote>美联储表示，最早可能在11月开始减少月度债券购买，并暗示加息可能会比预期更快。</blockquote></p><p> Fed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.</p><p><blockquote>美联储主席杰罗姆·鲍威尔周四对立法者表示，他预计未来几个月高通胀将有所缓解。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145898013","content_text":"WASHINGTON(Reuters)-U.S. consumer spending increased more than expected in August, but a downward revision to July data kept intact expectations that economic growth slowed in the third quarter as a resurgence in COVID-19 infections curbed demand for services.\nDow added 260 points, or 0.8%. The S&P 500 and the Nasdaq Composite rose 0.5% and 0.2%, respectively.Shares of Dow member Merck$(MRK)$ jumped 8% after the drug maker and Ridgeback Biotherapeuticssaid their oral antiviral treatment for Covid-19reduced the risk of hospitalization or death by 50% for patients with mild or moderate cases. The companies plan to seek emergency authorization for the treatment.The Commerce Department said on Friday that consumer spending, which accounts for more than two-thirds of U.S. economic activity, rebounded 0.8% in August, shrugging off declining motor vehicle sales caused by a global shortage of semiconductors, which is undercutting the production of automobiles.\nThe new drug from Merck appeared to boost travel stocks. Shares of Royal Caribbean and Las Vegas Sands added more than 1% in premarket trading. Southwest Airlines led a gain in airline stocks after JPMorganupgraded the stockand said most of the group was worth buying for a trade.\nThe 10-year Treasury yield fell back below 1.50% in early trading. Futures on the tech-heavy Nasdaq went into the green as yields fell.\nThe market just capped a tumultuous September as inflation fears, slowing growth and rising rates kept investors on edge. The S&P 500 finished the month down 4.8%, breaking a seven-month winning streak. The Dow and the Nasdaq Composite fell 4.3% and 5.3%, respectively, suffering their worst months of the year.\n“A combination of slowing growth, less accommodative monetary policy, China headwinds, fading fiscal stimulus, and nagging supply chain bottlenecks all conspired to weigh on investor sentiment as we head into fall and 4Q21,” Chris Hussey, a managing director at Goldman Sachs, said in a note.\nConsumer spending grew at a robust 12.0% annualized rate in the second quarter, accounting for much of the economy's 6.7% growth pace, which raised the level of gross domestic product above its peak in the fourth quarter of 2019. Growth estimates for the third quarter are below a 5.0% rate.\n\"Consumer momentum should improve in the months ahead, driving the economy closer to a full post-pandemic recovery and keeping inflation hot,\" said David Kelly, chief global strategist at JPMorgan Funds in New York.\nInflation maintained its upward trend in August. The personal consumption expenditures (PCE) price index, excluding the volatile food and energy components, climbed 0.3% after increasing by the same margin in July.\nIn the 12 months through August, the so-called core PCE price index increased 3.6%, matching July's gain.\nThe core PCE price index is the Federal Reserve's preferred inflation measure for its flexible 2% target. The Fed last week upgraded its core PCE inflation projection for this year to 3.7% from 3.0% back in June.\nThe U.S. central bank said it would likely begin reducing its monthly bond purchases as soon as November and signaled interest rate increases may follow more quickly than expected.\nFed Chair Jerome Powell told lawmakers on Thursday that he anticipated some relief from high inflation in the months ahead.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":1701,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865029072,"gmtCreate":1632924913261,"gmtModify":1632924913434,"author":{"id":"3580341419226466","authorId":"3580341419226466","name":"KenT","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580341419226466","idStr":"3580341419226466"},"themes":[],"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/865029072","repostId":"1125376817","repostType":4,"repost":{"id":"1125376817","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632924676,"share":"https://www.laohu8.com/m/news/1125376817?lang=zh_CN&edition=full","pubTime":"2021-09-29 22:11","market":"us","language":"en","title":"Greenidge Generation stock poped 33% in morning trading<blockquote>Greenidge Generation股价早盘上涨33%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1125376817","media":"Tiger Newspress","summary":"Greenidge Generation stock poped 33% in morning trading.\n\nWhile not an original meme stock, Greenrid","content":"<p>Greenidge Generation stock poped 33% in morning trading.</p><p><blockquote>Greenidge Generation股价早盘上涨33%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/5ce80faa7dce0ca81b0905ab01b5e40f\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> While not an original meme stock, Greenridge Generation is included because it recentlyclosed its merger with Support.com, a relative newcomer to the meme trade. As the name suggests, the latter is a big player in the customer support sector.</p><p><blockquote>虽然不是原创meme股票，但Greenridge Generation被纳入其中，因为它最近完成了与Support的合并。com是meme行业的相对新人。顾名思义，后者是客户支持领域的重要参与者。</blockquote></p><p> Its meme status may surprise investors — what would retail investors want to do with a customer support company?</p><p><blockquote>它的模因地位可能会让投资者感到惊讶——散户投资者想对客户支持公司做什么？</blockquote></p><p> The reasons come down to its now-closed merger with Greenridge Generation, a Bitcoin mining company. If you think crypto miners and meme stock investors go together, you’re right.</p><p><blockquote>原因可以归结为其与比特币矿业公司Greenridge Generation现已完成的合并。如果您认为加密货币矿工和模因股票投资者是相辅相成的，那么您是对的。</blockquote></p><p> Indeed, this merger provides investors with a leveraged way to invest in crypto. The company’s combined operations and ambitious growth plans have encouraged speculators of all stripes to consider this stock. Accordingly, Support.com somewhat quietly gained popularity prior to the merger.</p><p><blockquote>事实上，这次合并为投资者提供了一种投资加密货币的杠杆方式。该公司的综合业务和雄心勃勃的增长计划鼓励各种投机者考虑这只股票。因此，Support.com在合并之前悄然流行起来。</blockquote></p><p> Given the hype around the crypto space of late, I expect to see momentum with GREE stock.Investors looking for meme stocks that could run certainly have reason to consider this one right now.</p><p><blockquote>鉴于最近围绕加密货币领域的炒作，我预计格力股票将出现上涨势头。寻找可能上涨的模因股票的投资者现在当然有理由考虑这只股票。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Greenidge Generation stock poped 33% in morning trading<blockquote>Greenidge Generation股价早盘上涨33%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGreenidge Generation stock poped 33% in morning trading<blockquote>Greenidge Generation股价早盘上涨33%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-09-29 22:11</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Greenidge Generation stock poped 33% in morning trading.</p><p><blockquote>Greenidge Generation股价早盘上涨33%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/5ce80faa7dce0ca81b0905ab01b5e40f\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> While not an original meme stock, Greenridge Generation is included because it recentlyclosed its merger with Support.com, a relative newcomer to the meme trade. As the name suggests, the latter is a big player in the customer support sector.</p><p><blockquote>虽然不是原创meme股票，但Greenridge Generation被纳入其中，因为它最近完成了与Support的合并。com是meme行业的相对新人。顾名思义，后者是客户支持领域的重要参与者。</blockquote></p><p> Its meme status may surprise investors — what would retail investors want to do with a customer support company?</p><p><blockquote>它的模因地位可能会让投资者感到惊讶——散户投资者想对客户支持公司做什么？</blockquote></p><p> The reasons come down to its now-closed merger with Greenridge Generation, a Bitcoin mining company. If you think crypto miners and meme stock investors go together, you’re right.</p><p><blockquote>原因可以归结为其与比特币矿业公司Greenridge Generation现已完成的合并。如果您认为加密货币矿工和模因股票投资者是相辅相成的，那么您是对的。</blockquote></p><p> Indeed, this merger provides investors with a leveraged way to invest in crypto. The company’s combined operations and ambitious growth plans have encouraged speculators of all stripes to consider this stock. Accordingly, Support.com somewhat quietly gained popularity prior to the merger.</p><p><blockquote>事实上，这次合并为投资者提供了一种投资加密货币的杠杆方式。该公司的综合业务和雄心勃勃的增长计划鼓励各种投机者考虑这只股票。因此，Support.com在合并之前悄然流行起来。</blockquote></p><p> Given the hype around the crypto space of late, I expect to see momentum with GREE stock.Investors looking for meme stocks that could run certainly have reason to consider this one right now.</p><p><blockquote>鉴于最近围绕加密货币领域的炒作，我预计格力股票将出现上涨势头。寻找可能上涨的模因股票的投资者现在当然有理由考虑这只股票。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GREE":"Greenidge Generation Holdings Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1125376817","content_text":"Greenidge Generation stock poped 33% in morning trading.\n\nWhile not an original meme stock, Greenridge Generation is included because it recentlyclosed its merger with Support.com, a relative newcomer to the meme trade. As the name suggests, the latter is a big player in the customer support sector.\nIts meme status may surprise investors — what would retail investors want to do with a customer support company?\nThe reasons come down to its now-closed merger with Greenridge Generation, a Bitcoin mining company. If you think crypto miners and meme stock investors go together, you’re right.\nIndeed, this merger provides investors with a leveraged way to invest in crypto. The company’s combined operations and ambitious growth plans have encouraged speculators of all stripes to consider this stock. Accordingly, Support.com somewhat quietly gained popularity prior to the merger.\nGiven the hype around the crypto space of late, I expect to see momentum with GREE stock.Investors looking for meme stocks that could run certainly have reason to consider this one right now.","news_type":1,"symbols_score_info":{"GREE":0.9}},"isVote":1,"tweetType":1,"viewCount":1806,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862998680,"gmtCreate":1632825810606,"gmtModify":1632825810606,"author":{"id":"3580341419226466","authorId":"3580341419226466","name":"KenT","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580341419226466","idStr":"3580341419226466"},"themes":[],"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862998680","repostId":"2170624172","repostType":4,"isVote":1,"tweetType":1,"viewCount":2138,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":866394415,"gmtCreate":1632732254937,"gmtModify":1632798238481,"author":{"id":"3580341419226466","authorId":"3580341419226466","name":"KenT","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580341419226466","idStr":"3580341419226466"},"themes":[],"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/866394415","repostId":"2170488786","repostType":4,"repost":{"id":"2170488786","kind":"news","pubTimestamp":1632685409,"share":"https://www.laohu8.com/m/news/2170488786?lang=zh_CN&edition=full","pubTime":"2021-09-27 03:43","market":"other","language":"en","title":"Debt ceiling debates in Congress, consumer confidence: What to know this week<blockquote>国会债务上限辩论、消费者信心：本周需要了解什么</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2170488786","media":"Yahoo Finance","summary":"Investors this week are set to closely monitor developments in Washington, D.C., as lawmakers race t","content":"<p><div> Investors this week are set to closely monitor developments in Washington, D.C., as lawmakers race to pass legislation to avoid a government shutdown by the end of the month and debate raising the ...</p><p><blockquote><div>投资者本周将密切关注华盛顿特区的事态发展，因为议员们竞相通过立法，以避免政府在本月底关闭，并就提高...</div></blockquote></p><p> <a href=\"https://finance.yahoo.com/news/debt-ceiling-debates-in-congress-consumer-confidence-what-to-know-this-week-194329712.html\">网页链接</a> </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/debt-ceiling-debates-in-congress-consumer-confidence-what-to-know-this-week-194329712.html\">网页连接</a></blockquote></p><p></p>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Debt ceiling debates in Congress, consumer confidence: What to know this week<blockquote>国会债务上限辩论、消费者信心：本周需要了解什么</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDebt ceiling debates in Congress, consumer confidence: What to know this week<blockquote>国会债务上限辩论、消费者信心：本周需要了解什么</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Yahoo Finance</strong><span class=\"h-time small\">2021-09-27 03:43</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> Investors this week are set to closely monitor developments in Washington, D.C., as lawmakers race to pass legislation to avoid a government shutdown by the end of the month and debate raising the ...</p><p><blockquote><div>投资者本周将密切关注华盛顿特区的事态发展，因为议员们竞相通过立法，以避免政府在本月底关闭，并就提高...</div></blockquote></p><p> <a href=\"https://finance.yahoo.com/news/debt-ceiling-debates-in-congress-consumer-confidence-what-to-know-this-week-194329712.html\">网页链接</a> </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/debt-ceiling-debates-in-congress-consumer-confidence-what-to-know-this-week-194329712.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/debt-ceiling-debates-in-congress-consumer-confidence-what-to-know-this-week-194329712.html\">Yahoo Finance</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e7e749e88d2580d292ffc6ae18d03b65","relate_stocks":{"SPY.AU":"SPDR® S&P 500® ETF Trust"},"source_url":"https://finance.yahoo.com/news/debt-ceiling-debates-in-congress-consumer-confidence-what-to-know-this-week-194329712.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170488786","content_text":"Investors this week are set to closely monitor developments in Washington, D.C., as lawmakers race to pass legislation to avoid a government shutdown by the end of the month and debate raising the debt ceiling. Elsewhere, economic data on consumer confidence is also due for release.\nThe Senate is expected to vote Monday on a procedural motion over the legislation passed by the House of Representatives last week. That bill included a plan to temporarily fund the government through early December, and came alongside a measure to raise the government debt ceiling through December 2022.\nThe latter point has been an area of contention for Senate Republicans, who are only narrowly outnumbered by Democratic lawmakers in both chambers and who have threatened to block the bill in its current form.\nSenate Republicans including Minority Leader Mitch McConnell have suggested that Democratic lawmakers should use the budget reconciliation process to raise the debt ceiling without Republican support. McConnell has, however, supported a short-term government funding bill that excludes a debt ceiling suspension.\n\"If they [the Democrats] want to tax, borrow and spend historic sums of money without our input, they’ll have to raise the debt limit without our help. This is the reality,” McConnell said on the Senate floor last week.\nDemocratic lawmakers, for their part, have called for the move to raise the debt limit be bipartisan to prevent the government from defaulting on its obligations. The Treasury Department has warned that the U.S. could default on its debts as soon as October in absence of congressional action.\n\"The U.S. has always paid its bills on time, but the overwhelming consensus among economists and Treasury officials of both parties is that failing to raise the debt limit would produce widespread economic catastrophe,\" Treasury Secretary Janet Yellen wrote in an op-ed in the Wall Street Journal last week.\nFederal Reserve Chair Jerome Powell also warned of the consequences of a failure to raise the debt ceiling during his post-FOMC meeting press conference last week.\n\"It's just very important that the debt ceiling be raised in a timely fashion so that the United States can pay its bills when and as they come due. That's a critically important thing,\" he said. \"The failure to do that is something that could result in severe reactions, severe damage to the economy and to the financial markets ... no one should assume that the Fed or anyone else can protect the markets or the economy in the event of a failure.\"\nA dead Elm tree is removed on the West Front of the Capitol in Washington, Friday, Sept. 10, 2021. (AP Photo/J. Scott Applewhite)ASSOCIATED PRESS\nAmid the standoff, the Office of Management and Budget began warning federal agencies last week to prepare for a potential government shutdown. The reminder served as a standard warning one week out from Congress's deadline to reach an agreement to at least temporarily continue funding the government.\nThough leaders of both political parties have agreed that a continuing resolution to avoid the shutdown at the end of the month is needed, the ongoing tension over raising the debt limit has served as a potential roadblock in this effort.\n\"We still expect Congress to avert a partial government shutdown at the start of October. Republicans won’t vote for the current continuing resolution being touted by the Democratic leadership, which also includes a new debt ceiling suspension,\" wrote Paul Ashworth, chief North America economist for Capital Economics, in a note Friday. \"But we expect a Plan B to emerge next week with the latter stripped out, which Republicans will support.\"\n\"The bigger issue is that there doesn’t appear to be an easy path to raising the debt ceiling by mid-October, which is when estimates suggest the Treasury’s will exhaust the 'extraordinary measures it is currently using to keep the lights on,\" he added.\nInvestors have also grown jittery as the debates wore on, with stocks posting their worst day since May last week amid a confluence of concerns that also included debt concerns with China Evergrande.\nMany strategists, however, have suggested market participants need not be overly concerned about the impacts of a potential government shutdown.\n\"Historically, we've seen that government shutdowns tend to be short-lived,\" Jordan Jackson, JPMorgan Asset Management global market strategist, told Yahoo Finance Live on Friday. \"We also know that for those non-essential federal employees, they do get furlough pay as well.\"\n\"If it lasts more than 30 days, it's certainly going to have a bigger impact on the economy. But generally speaking, these shutdowns tend to be short-lived and markets — while they may correct in the short-term — they do sort of continue to grind higher,\" he added. \"I think it's certainly a risk in terms of a short-term mini correction there. But again, with all the liquidity out there, I think any sort of blip in the markets will be short-lived.\"\nHistorical equity performance during and immediately following a government shutdown has also tended to point to a muted market impact.\n\"In the 14 government shutdowns since 1980, the S&P 500 generated median returns of -0.1% on the dates of budget authority expiration, 0.1% during the shutdown periods, and 0.3% on the dates of resolution,\" David Kostin, Goldman Sachs chief equity strategist, wrote in a note published on Sept. 21.\n\"One notable exception was the most recent federal shutdown in December 2018, when the S&P 500 fell 2% on the spending authority expiration date,\" he added. \"However, this decline was likely driven primarily by investor concerns about Fed tightening.\"\nKostin also noted that the typical government shutdown since 1980 has only lasted three days before ultimately being resolved. More recent shutdowns have lasted several times longer, however, with the duration of the four most recent federal shutdowns averaging 18 days, Kostin said.\nConsumer confidence\nOn the economic data front, one of the most closely watched new pieces of data will be on consumer confidence.\nThe Conference Board is set to release its September consumer confidence index Tuesday morning. Economists expect the index to tick up only slightly compared to August, with consumers' views on the coronavirus and rising prices stabilizing near the lowest level since February.\nSpecifically, consensus economists are looking for the index to rise to 115.0 in September after dropping to 113.8 in August. During the last monthly report, consumers' assessments of current business and labor market conditions both eased, and expectations for the next six months out also deteriorated.\n\"Consumer confidence fell to a six-month low in August, due to concerns around the Delta variant and inflation,\" wrote Bank of America economist Michelle Meyer in a note on Friday. \"We think these concerns largely remained in September.\"\nAt the time, Lynn Franco, senior director of economic indicators at the Conference Board, said it was still \"too soon to conclude\" whether decline in consumer confidence would \"result in consumers significantly curtailing their spending in the months ahead.\"\nThe latest spending data has also been equivocal. The Commerce Department's latest report showed retail sales rose 0.7% in August after declining in July. However, the categories posting the biggest declines were areas like e-commerce shops and grocery stores, suggesting consumer behavior was shifting back toward stay-in-place trends and away from in-person events like restaurant dining amid the latest wave of the coronavirus.\nEconomic calendar\n\nMonday: Durable goods orders, August preliminary (0.6% expected, -0.1% in July); Durable goods excluding transportation, August preliminary (0.5% expected, 0.8% in July); Non-defense capital goods orders excluding aircraft, August preliminary (0.3% expected, 0.1% in July); Non-defense capital goods orders excluding aircraft, August preliminary (0.9% in July); Dallas Fed Manufacturing Activity Index, September (11.0 expected, 9.0 in July)\nTuesday: Advance goods trade balance, August (-$87.0 billion expected, -$86.4 billion in July); Wholesale inventories, month-over-month, August preliminary (0.6% in July); Retail inventories, month-over-month, August (0.4% in July); FHFA House Price Index, month-over-month, July (1.5% expected, 1.6% in July); S&P CoreLogic Case-Shiller 20-City Composite Index, month-over-month, July (1.62% expected, 1.77% in June); S&P CoreLogic Case-Shiller 20-City Composite Index, month-over-month, July (20.1% expected, 19.08% in June); Conference Board Consumer Confidence Index, September (114.2 expected, 113.8 in August); Richmond Fed Manufacturing Index, September (9 in August)\nWednesday: MBA Mortgage Applications, week ended September 24 (4.9% during prior month); Pending home sales, month-over-month, August (1.0% expected, -1.8% in July)\nThursday: Initial jobless claims, week ended September 25 (320,000 expected, 351,000 during prior week); Continuing claims, week ended September 18 (2.845 million during prior week); GDP annualized, quarter-over-quarter, second-quarter third estimate (6.7% expected, 6.6% in prior estimate); Personal consumption, second-quarter third estimate (11.9% in prior estimate); Core personal consumption expenditures, second quarter third estimate (6.1% in prior estimate); MNI Chicago PMI, September (65.0 expected, 66.8 in August)\nFriday: Personal income, August (0.2% expected, 1.1% in July); Personal spending, August (0.7% expected, 0.3% in July); Personal consumption expenditures core deflator, month-over-over, August (0.2% expected, 0.3% in July); Personal consumption expenditures core deflator, year-over-year, August (3.6% expected, 3.6% in July); Markit manufacturing PMI, September final (60.5 in prior estimate); Construction spending, month-over-month, August (0.3% expected, 0.3% in July); University of Michigan sentiment, September final (71.0 expected, 71.0 in prior print); ISM Manufacturing, September (59.5 expected, 59.9 in August)\n\nEarnings calendar\n\nMonday: Aurora Cannabis (ACB) after market close\nTuesday: Micron Technology (MU) after market close.\nWednesday: No notable reports scheduled for release\nThursday: CarMax (KMX), Bed Bath & Beyond (BBBY) before market open; Jefferies (JEF) after market close\nFriday: No notable reports scheduled for releas","news_type":1,"symbols_score_info":{"SPY.AU":0.9}},"isVote":1,"tweetType":1,"viewCount":1917,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":860760285,"gmtCreate":1632214565647,"gmtModify":1632802026880,"author":{"id":"3580341419226466","authorId":"3580341419226466","name":"KenT","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3580341419226466","idStr":"3580341419226466"},"themes":[],"htmlText":"D","listText":"D","text":"D","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860760285","repostId":"1169324317","repostType":4,"isVote":1,"tweetType":1,"viewCount":1685,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}